Quick Answer
Connect Biopharma Holdings Ltd reported Net Income Loss of -$55.48 million for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -255.0% in Net Income Loss from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Connect Biopharma Holdings Ltd's Net Income Loss has grown by 10.7%.
- Historical annual values: Fiscal year 2025: -$55.48 million | Fiscal year 2024: -$15.63 million | Fiscal year 2023: -$62.11 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: